Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

206 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The mechanosensitive TRPV2 calcium channel promotes human melanoma invasiveness and metastatic potential.
Shoji KF, Bayet E, Leverrier-Penna S, Le Devedec D, Mallavialle A, Marionneau-Lambot S, Rambow F, Perret R, Joussaume A, Viel R, Fautrel A, Khammari A, Constantin B, Tartare-Deckert S, Penna A. Shoji KF, et al. Among authors: khammari a. EMBO Rep. 2023 Apr 5;24(4):e55069. doi: 10.15252/embr.202255069. Epub 2023 Feb 6. EMBO Rep. 2023. PMID: 36744297 Free PMC article.
The epithelial-mesenchymal transition (EMT) regulatory factor SLUG (SNAI2) is a downstream target of SPARC and AKT in promoting melanoma cell invasion.
Fenouille N, Tichet M, Dufies M, Pottier A, Mogha A, Soo JK, Rocchi S, Mallavialle A, Galibert MD, Khammari A, Lacour JP, Ballotti R, Deckert M, Tartare-Deckert S. Fenouille N, et al. Among authors: khammari a. PLoS One. 2012;7(7):e40378. doi: 10.1371/journal.pone.0040378. Epub 2012 Jul 20. PLoS One. 2012. PMID: 22911700 Free PMC article.
Histopathological aspects of cutaneous erythematous-papular eruptions induced by immune checkpoint inhibitors for the treatment of metastatic melanoma.
Perret RE, Josselin N, Knol AC, Khammari A, Cassecuel J, Peuvrel L, Dreno B; Supported by GESTIM Nantes group of cutaneous adverse events induced by anticancer drugs. Perret RE, et al. Among authors: khammari a. Int J Dermatol. 2017 May;56(5):527-533. doi: 10.1111/ijd.13540. Epub 2017 Feb 10. Int J Dermatol. 2017. PMID: 28188628
Management and outcome of metastatic melanoma during pregnancy.
Pagès C, Robert C, Thomas L, Maubec E, Sassolas B, Granel-Brocard F, Chevreau C, De Raucourt S, Leccia MT, Fichet D, Khammari A, Boitier F, Stoebner PE, Dalac S, Celerier P, Aubin F, Viguier M. Pagès C, et al. Among authors: khammari a. Br J Dermatol. 2010 Feb 1;162(2):274-81. doi: 10.1111/j.1365-2133.2009.09240.x. Epub 2009 May 21. Br J Dermatol. 2010. PMID: 19804595
Serum soluble HLA-E in melanoma: a new potential immune-related marker in cancer.
Allard M, Oger R, Vignard V, Percier JM, Fregni G, Périer A, Caignard A, Charreau B, Bernardeau K, Khammari A, Dréno B, Gervois N. Allard M, et al. Among authors: khammari a. PLoS One. 2011;6(6):e21118. doi: 10.1371/journal.pone.0021118. Epub 2011 Jun 21. PLoS One. 2011. PMID: 21712991 Free PMC article.
Blood Predictive Biomarkers for Nivolumab in Advanced Melanoma.
Chasseuil E, Saint-Jean M, Chasseuil H, Peuvrel L, Quéreux G, Nguyen JM, Gaultier A, Varey E, Khammari A, Dréno B. Chasseuil E, et al. Among authors: khammari a. Acta Derm Venereol. 2018 Apr 16;98(4):406-410. doi: 10.2340/00015555-2872. Acta Derm Venereol. 2018. PMID: 29327065 Free article.
206 results